Lannett Company
LCI
#10382
Rank
A$11.11 M
Marketcap
A$1.03
Share price
0.00%
Change (1 day)
-70.81%
Change (1 year)

Lannett Company (LCI) - Cash on Hand

Cash on Hand as of March 2023 : A$70.06 Million

According to Lannett Company's latest financial reports the company has A$70.06 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lannett Company - Cash on Hand chart (from 2000 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-06-30A$0.12 B2.37%
2021-06-30A$0.12 B-40.5%
2020-06-30A$0.20 B4.72%
2019-06-30A$0.19 B49.95%
2018-06-30A$0.13 B-29.4%
2017-06-30A$0.18 B-41.18%
2016-06-30A$0.32 B15.4%
2015-06-30A$0.27 B79.13%
2014-06-30A$0.15 B176.87%
2013-06-30A$56.02 M96.34%
2012-06-30A$28.53 M24.04%
2011-06-30A$23 M-13.39%
2010-06-30A$26.56 M-17.92%
2009-06-30A$32.36 M394.68%
2008-06-30A$6.54 M6.68%
2007-06-30A$6.13 M868.43%
2006-06-30A$0.63 M-88.4%
2005-06-30A$5.45 M-57.95%
2004-06-30A$12.98 M145.74%
2003-06-30A$5.28 M
1999-06-30A$0.15 M462.44%
1998-06-30A$0.02 M30.92%
1997-06-30A$0.02 M-35.98%
1996-06-30A$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
A$22.55 B 32,095.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.94 B 39,783.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.64 B 16,515.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$14.68 B 20,856.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
A$6.69 B 9,449.59%๐Ÿ‡ฌ๐Ÿ‡ง UK